Elizabeth Barnhard Recognized in 2024 IAM Strategy 300

Leason Ellis congratulates Elizabeth Barnhard for her nomination and inclusion in the 2024 IAM Strategy 300. Elizabeth was ranked in the areas of Biotech, IP management consultancy, and Pharmaceuticals/Life Sciences. She serves as the Chair of the Leason Ellis Pharma/Biotech Practice Group. The IAM Strategy 300 recognizes the top practitioners in IP strategy and portfolio management. Individuals are nominated by IAM readers and members of the global patent community. Those identified by market sources for their exceptional skill sets and profound insights into patent matters are featured in the final IAM Strategy 300 rankings.